Target intelligence / Profile preview

RNA, U6 small nuclear 528, pseudogene (RNU6-528P)

Target
RNU6-528P
Molecular classification
Other (RNA pseudogene; does not fall under receptor, enzyme, transporter, etc.)
01

Overview

RNA, U6 small nuclear 528, pseudogene (RNU6-528P) is a transcribed pseudogene based on the highly conserved U6 small nuclear RNA (snRNA) sequence[4][5]. U6 snRNA itself is a non-coding RNA that forms part of the spliceosome, the cellular machinery responsible for the removal of introns from pre-mRNA in eukaryotes[3]. U6-derived pseudogenes like RNU6-528P are numerous in vertebrate genomes, a possible reflection of the U6 gene’s evolutionary and functional importance[3][5]. However, these pseudogenes, including RNU6-528P, are typically non-functional, do not code for active spliceosomal RNA, and are not recognized as therapeutic targets or regulators in established drug or disease pathways[2][6]. Their functional role, if any, is not well defined, and the majority remain transcriptionally inactive or non-functional in current evidence[6]. RNU6-528P is a transcribed RNA pseudogene, unrelated to receptors, enzymes, or other canonical drug targets; there is no established functional, therapeutic, or disease relevance for this molecule.

Other names
RNU6-528PRNA, U6 small nuclear 528, pseudogene
02

Mechanism of action

None applicable

03

Biological functions

None established for this pseudogene; parental U6 snRNA is essential in pre-mRNA splicing, but the pseudogene does not perform this function
04

Disease associations

Unknown; while some pseudogenes are implicated in gene regulation or act as competitive endogenous RNAs, there is no specific evidence for RNU6-528P

Beyond the preview

Go deeper on RNA, U6 small nuclear 528, pseudogene (RNU6-528P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 528, pseudogene (RNU6-528P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call